Skip to main content
Retour
Watch Compare

Forte Biosciences, Inc.

Qualité des données : 83%
FBRX
NASDAQ Manufacturing Chemicals
35,09 €
▲ 1,19 € (3,51%)
Cap. Boursière: 472,11 M
Prix
34,00 €
Cap. Boursière
472,11 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -51,00 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-75,94%
En dessous de la moyenne du secteur (-53,58%)
ROIC-61,10%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio7,34
Interest Coverage-26,02

Valorisation

PE (TTM)
-6,81
En dessous de la moyenne du secteur (-1,48)
P/B Ratio5,61
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -6,8 -1,5
P/B 5,6 1,6
ROE % -75,9 -53,6
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

4 analystes
Buy
Actuel
35,09 €
+81.7%
Objectif
63,75 €
54,00 €
63,00 €
75,00 €
Prévisions
P/E Prévisionnel -8,12
BPA Prévisionnel -4,32 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -4,32 €
-5,25 € – -3,26 €
 0,0 5
FY2026 -4,34 €
-4,78 € – -3,87 €
 0,0 5

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -1,15 € -1,45 € -26,4%
Q32025 -1,07 € -0,99 € +7,3%
Q22025 -1,11 € -0,96 € +13,3%
Q12025 -0,95 € -1,37 € -44,2%

ETFs Holding This Stock

AHSCX AHSCX
5,49% weight
AHSAX AHSAX
5,49% weight
AHSZX AHSZX
5,49% weight
AASOX AASOX
2,41% weight
ATVPX ATVPX
1,44% weight
AGSCX AGSCX
0,82% weight
ASCYX ASCYX
0,82% weight
ASCZX ASCZX
0,82% weight
ALSCX ALSCX
0,82% weight
ALSAX ALSAX
0,82% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -69,38 M
ROE -75,94% ROA -67,73%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51,00 M
ROIC -61,10% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7,34
Interest Coverage -26,02 Asset Turnover N/A
Working Capital 82,42 M Tangible Book Value 84,10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,81 Forward P/E N/A
P/B Ratio 5,61 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,80%
Market Cap 472,11 M Enterprise Value 378,70 M
Per Share
EPS (Diluted TTM) -4,71 Revenue / Share N/A
FCF / Share -3,67 OCF / Share -3,66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 73,51%
SBC-Adj. FCF -56,38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -69,38 M -35,48 M -31,48 M -13,88 M -21,71 M
EPS (Diluted) -4,71 -12,17 -1,00 -0,80 —
Gross Profit — — — — —
Operating Income -70,66 M -36,60 M -32,49 M -13,90 M -21,49 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2,72 M 1,31 M 1,12 M — —
Income Tax 1,04 M — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 82,78 M 61,56 M 38,98 M 42,00 M 43,31 M
Total Liabilities 21,79 M — — — —
Shareholders' Equity 60,99 M 52,48 M 35,31 M 38,82 M 41,55 M
Total Debt — — — — —
Cash & Equivalents 76,96 M 22,24 M 37,13 M 41,10 M 42,04 M
Current Assets 80,59 M 61,35 M 38,33 M 41,51 M 42,52 M
Current Liabilities 20,75 M 9,08 M 3,67 M 3,18 M 1,76 M